Biocomposites to distribute its NanoBone® product range in the UK
• NanoBone® is a next-generation osteoinductive bone graft consisting of patented nanostructured hydroxyapatite for remodelling bone
• Biocomposites to introduce NanoBone at the British Orthopaedic Association’s Annual Congress in Birmingham
• Biocomposites to introduce NanoBone at the British Orthopaedic Association’s Annual Congress in Birmingham
Keele, UK, 12 September 2024 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue, today announces that it will begin distributing its NanoBone range of products in the UK. The range consists of NanoBone SBX Putty and NanoBone QD, which are next generation synthetic bone grafts that provide reliable early osteogenesis and bone formation.
